(Q39983690)

English

Cyclophosphamide-refractory scleroderma-associated interstitial lung disease: remarkable clinical and radiological response to a single course of rituximab combined with high-dose corticosteroids

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Cyclophosphamide-refractory scleroderma-associated interstitial lung disease: remarkable clinical and radiological response to a single course of rituximab combined with high-dose corticosteroids (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

interstitial lung disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Muhammad Haroon

1

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Patrick McLaughlin

2

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Michael Henry

3

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Sinead Harney

4

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

publication date

18 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Therapeutic advances in respiratory disease

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

299-304

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial

1 reference

https://api.crossref.org/works/10.1177%2F1753465811407786

21 January 2018

Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome.

1 reference

https://api.crossref.org/works/10.1177%2F1753465811407786

21 January 2018

Progressive multifocal leucoencephalopathy in the rheumatic diseases: assessing the risks of biological immunosuppressive therapies

1 reference

https://api.crossref.org/works/10.1177%2F1753465811407786

21 January 2018

Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study

1 reference

https://api.crossref.org/works/10.1177%2F1753465811407786

21 January 2018

Is there a role for B-cell depletion as therapy for scleroderma? A case report and review of the literature.

1 reference

https://api.crossref.org/works/10.1177%2F1753465811407786

21 January 2018

Unique characteristics of systemic sclerosis sine scleroderma-associated interstitial lung disease

1 reference

https://api.crossref.org/works/10.1177%2F1753465811407786

21 January 2018

Clinically significant interstitial lung disease in limited scleroderma: histopathology, clinical features, and survival

1 reference

https://api.crossref.org/works/10.1177%2F1753465811407786

21 January 2018

PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY AFTER RITUXIMAB IN A CASE OF NON-HODGKIN LYMPHOMA

1 reference

https://api.crossref.org/works/10.1177%2F1753465811407786

21 January 2018

B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1753465811407786

21 January 2018

Progressive systemic sclerosis sine scleroderma presenting as pulmonary interstitial fibrosis

1 reference

https://api.crossref.org/works/10.1177%2F1753465811407786

21 January 2018

Successful treatment of resistant scleroderma-associated interstitial lung disease with rituximab

1 reference

https://api.crossref.org/works/10.1177%2F1753465811407786

21 January 2018

Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes.

1 reference

https://api.crossref.org/works/10.1177%2F1753465811407786

21 January 2018

CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse

1 reference

https://api.crossref.org/works/10.1177%2F1753465811407786

21 January 2018

Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells

1 reference

https://api.crossref.org/works/10.1177%2F1753465811407786

21 January 2018

Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study

1 reference

https://api.crossref.org/works/10.1177%2F1753465811407786

21 January 2018

Changes in causes of death in systemic sclerosis, 1972-2002

1 reference

https://api.crossref.org/works/10.1177%2F1753465811407786

21 January 2018

Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.

1 reference

https://api.crossref.org/works/10.1177%2F1753465811407786

21 January 2018

Systemic and cell type-specific gene expression patterns in scleroderma skin

1 reference

https://api.crossref.org/works/10.1177%2F1753465811407786

21 January 2018

Late-onset neutropenia after rituximab treatment: case series and comprehensive review of the literature

1 reference

https://api.crossref.org/works/10.1177%2F1753465811407786

21 January 2018

Identifiers

10.1177/1753465811407786

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

release_jzldhaatwzdy5ez6rhs5dppjmm

1 reference

https://api.fatcat.wiki/v0/release/jzldhaatwzdy5ez6rhs5dppjmm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39983690&oldid=1881715172"